Ambea AB (publ) (STO:AMBEA)
Sweden
· Delayed Price · Currency is SEK 114.10
+0.30 (0.26%)
Apr 29, 2025, 9:59 AM CET
Ambea AB Revenue
In the year 2024, Ambea AB had annual revenue of 14.32B SEK with 5.53% growth. Ambea AB had revenue of 3.76B in the quarter ending December 31, 2024, with 2.56% growth.
Revenue
14.32B
Revenue Growth
+5.53%
P/S Ratio
0.67
Revenue / Employee
378.20K
Employees
37,864
Market Cap
9.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.32B | 751.00M | 5.53% |
| Dec 31, 2023 | 13.57B | 934.00M | 7.39% |
| Dec 31, 2022 | 12.64B | 1.16B | 10.08% |
| Dec 31, 2021 | 11.48B | 395.00M | 3.56% |
| Dec 31, 2020 | 11.08B | 43.00M | 0.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Bonesupport Holding AB | 898.73M |
| Vitrolife AB | 3.61B |
| AddLife AB | 10.42B |
Ambea AB News
- 9 months ago - Ambea AB (FRA:6MA) Q2 2024 Earnings Call Transcript Highlights: Strong EBITDA Growth and ... - GuruFocus
- 9 months ago - Q2 2024 Ambea AB (publ) Earnings Call Transcript - GuruFocus